Kamada Ltd (KMDA)

Nov 13, 2024, 9:54 AM EST - 2 months ago

Kamada Ltd. (KMDA) Q3 2024 Earnings Call Transcript

Sep 23, 2024, 7:00 AM EDT - 4 months ago

Kamada Announces Expansion of Plasma Collection Operations in Texas with the Opening of New Site in Houston

Aug 14, 2024, 1:45 PM EDT - 5 months ago

Kamada Ltd. (KMDA) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 7:00 AM EDT - 5 months ago

Kamada to Announce Second Quarter and First Half Ended June 30, 2024 Financial Results and Host Conference Call on August 14, 2024

May 8, 2024, 11:55 AM EDT - 9 months ago

Kamada Ltd. (KMDA) Q1 2024 Earnings Call Transcript

May 8, 2024, 7:00 AM EDT - 9 months ago

Kamada Reports Strong First Quarter 2024 Financial Results with Year-Over-Year Top-Line Growth of 23% and a 96% Increase in Profitability; Raises Full-Year Financial Guidance

May 1, 2024, 7:00 AM EDT - 9 months ago

Kamada to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

Mar 6, 2024, 2:22 PM EST - 11 months ago

Kamada Ltd. (KMDA) Q4 2023 Earnings Call Transcript

Mar 6, 2024, 7:05 AM EST - 11 months ago

Kamada Issues 2024 CEO Letter to Shareholders

Mar 6, 2024, 7:00 AM EST - 11 months ago

Kamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results, and Provides Full-Year 2024 Guidance Representing Double-Digit Growth in Revenue and Profitability

Feb 28, 2024, 7:00 AM EST - 11 months ago

Kamada to Announce Fourth Quarter and Fiscal Year 2023 Financial Results, and Provide 2024 Financial Guidance on March 6, 2024

Dec 8, 2023, 6:42 PM EST - 1 year ago

Kamada: Kedrion Deal Locks In Growth

Dec 7, 2023, 11:00 AM EST - 1 year ago

KEDRION ANNOUNCES AN EIGHT-YEAR EXTENSION OF THE DISTRIBUTION AGREEMENT WITH KAMADA IN THE US FOR KEDRAB®

Dec 6, 2023, 7:00 AM EST - 1 year ago

Kamada Announces its Largest Commercial Agreement; A Strategic Engagement with Kedrion for U.S. Distribution of KEDRAB® including $180 Million of Revenues Over First Four Years

Dec 5, 2023, 12:00 PM EST - 1 year ago

Celebrating Seeking Alpha's New Analysts - November 2023 Edition

AGNC CROX DPZ FHI GRPN GRVY GTN

Nov 21, 2023, 10:11 AM EST - 1 year ago

Kamada: Solid Specialty Plasma Play

Nov 13, 2023, 11:08 AM EST - 1 year ago

Kamada Ltd. (KMDA) Q3 2023 Earnings Call Transcript

Nov 13, 2023, 7:00 AM EST - 1 year ago

Kamada Reports Significant Increase in Sales and Profitability in the Third Quarter and Nine Month 2023; Reiterates 2023 Revenue and Profitability Guidance

Nov 8, 2023, 7:00 AM EST - 1 year ago

Kamada to Announce Third Quarter and First Nine Months Ended September 30, 2023 Financial Results and Host Conference Call on November 13, 2023

Oct 10, 2023, 7:37 AM EDT - 1 year ago

Kamada Provides Corporate Update on its Israel Operations

Oct 9, 2023, 8:53 AM EDT - 1 year ago

These Israeli pharmaceutical stocks are down in the wake of Hamas attack

CGEN PLX TARO TEVA

Aug 30, 2023, 7:00 AM EDT - 1 year ago

Kamada Announces Shareholder Approval and Planned Closing of $60 Million Private Placement with FIMI Opportunity Funds

Aug 16, 2023, 3:53 PM EDT - 1 year ago

Kamada Ltd. (KMDA) Q2 2023 Earnings Call Transcript

Aug 16, 2023, 7:00 AM EDT - 1 year ago

Kamada Reports Strong Second Quarter and First Half 2023 Financial Results; Reiterates 2023 Revenue and Profitability Guidance

Aug 9, 2023, 7:00 AM EDT - 1 year ago

Kamada to Announce Second Quarter and First Half Ended June 30, 2023 Financial Results and Host Conference Call on August 16, 2023

Jul 12, 2023, 7:00 AM EDT - 1 year ago

Kamada Announces Kedrion Exercised its Option for Two-Year Extension of KEDRAB® Distribution Agreement in the U.S.

Jun 21, 2023, 5:10 AM EDT - 1 year ago

Kamada: Deep Dive Following FIMI Placement, Rate Buy

May 24, 2023, 1:21 PM EDT - 1 year ago

Kamada Ltd. (KMDA) Q1 2023 Earnings Call Transcript

May 24, 2023, 7:10 AM EDT - 1 year ago

Kamada Reports Strong First Quarter 2023 Financial Results; Reiterates Revenue and Profitability Guidance

May 24, 2023, 7:05 AM EDT - 1 year ago

Kamada Announces Chief Financial Officer Chaime Orlev to Remain in Role and Appointment of Nir Livneh as Vice President, General Counsel and Corporate Secretary

May 24, 2023, 7:00 AM EDT - 1 year ago

Kamada Announces $60 Million Private Placement with FIMI Opportunity Funds

May 17, 2023, 7:00 AM EDT - 1 year ago

Kamada to Announce First Quarter 2023 Financial Results and Host Conference Call on May 24, 2023

May 16, 2023, 7:00 AM EDT - 1 year ago

Kamada Announces Receipt of Marketing Authorization for Glassia® for Treatment of Alpha-1 Antitrypsin Deficiency in Switzerland

May 3, 2023, 7:00 AM EDT - 1 year ago

Kamada Announces U.S. FDA Approval of its Application to Manufacture CYTOGAM® at the Company's Facility in Israel

Mar 15, 2023, 4:07 PM EDT - 2 years ago

Kamada Ltd. (KMDA) Q4 2022 Earnings Call Transcript

Mar 15, 2023, 7:10 AM EDT - 2 years ago

Kamada Issues 2023 CEO Letter to Shareholders

Mar 15, 2023, 7:00 AM EDT - 2 years ago

Kamada Reports Strong Fiscal Year and Fourth Quarter 2022 Financial Results, and Provides 2023 Guidance Representing Significant Profitability Growth

Jan 4, 2023, 7:00 AM EST - 2 years ago

Kamada Announces Submission of Application to the U.S. FDA to Manufacture CYTOGAM® at the Company's Facility in Israel

Dec 19, 2022, 7:00 AM EST - 2 years ago

Kamada Announces Planned Transition of Chief Financial Officer

Nov 22, 2022, 10:35 AM EST - 2 years ago

Kamada Ltd. (KMDA) Q3 2022 Earnings Call Transcript

Nov 22, 2022, 7:00 AM EST - 2 years ago

Kamada Reports Strong Third Quarter Financial Results Demonstrating Successful Strategic Transition and Reiterates 2022 Financial Guidance

Oct 19, 2022, 7:00 AM EDT - 2 years ago

Kamada Awarded $22 Million Extension of Canadian Supply Tender

Aug 17, 2022, 1:58 PM EDT - 2 years ago

Kamada Ltd. (KMDA) CEO Amir London on Q2 2022 Results - Earnings Call Transcript

Aug 17, 2022, 7:00 AM EDT - 2 years ago

Kamada Reports Second Quarter and First Half 2022 Financial Results; Significant Growth Driven by Multiple Catalysts Expected in Second Half of 2022; Reiterates 2022 Revenue and Profitability Guidance

Aug 10, 2022, 7:00 AM EDT - 2 years ago

Kamada to Announce Second Quarter and First Half Ended June 30, 2022 Financial Results and Host Conference Call on August 17, 2022

Jul 15, 2022, 7:00 AM EDT - 2 years ago

Kamada Announces Resolution to the Labor Strike at the Company's Manufacturing Facility in Israel; A New, Eight-Year Collective Agreement Signed

Jul 6, 2022, 6:00 AM EDT - 2 years ago

Kamada Announces $11.4 Million International VARIZIG® Procurement Agreement

Jun 15, 2022, 7:00 AM EDT - 2 years ago

Kamada Strengthens Senior Leadership Team; Furthering Commitment as a Fully Integrated Global Leader in the Specialty Plasma-Derived Therapeutics Market

May 17, 2022, 11:06 AM EDT - 2 years ago

Kamada Ltd. (KMDA) CEO Amir London on Q1 2022 Results - Earnings Call Transcript

May 17, 2022, 7:05 AM EDT - 2 years ago

Kamada Reports First Quarter 2022 Financial Results; Reiterates Revenue and Profitability Guidance with Significant Growth Expected in 2022